[Data Observation] IM index futures shorts significantly increased positions, while frontline speculators are intensely competing for Founder Technology Group.
① The main contract for IM期指 saw short positions increase by nearly 10,000 lots, with the increase in quantity significantly greater than the long positions. ② In the PCB concept stocks, Founder Technology Group received Buy orders from two major speculative funds, while also experiencing Sell orders from two major speculative funds, including 0.285 billion bought by the Ningbo branch of Lianchu Securities.
Holiday Reading | SoundHound AI's tenfold growth in a year: The imagination of voice AI?
The rise of SOUN seems to have a certain degree of randomness, and compared to the APP, it is not that convincing. The core technology is not exclusive; with the price increase by OpenAI, the path to profit is opening up. The problem this company will face in the future is that while revenues may rise, profit margins are decreasing, and it may never be able to achieve profitability.
2024 is the "explosion year" for Asia Vets in autonomous driving: companies rushing to go public, aiming for a trillion-level market.
This year, the carrot racing on the streets of Wuhan has caught public attention, and Tesla's Self-Driving Cars robotaxi has unveiled its mysterious veil, with companies from China and the United States racing ahead in the Asia Vets driving track.
Market Cap 10.5 billion Hong Kong dollars! Iflytek Co.,ltd. Medical enters the Hong Kong stock market, and Liu Qingfeng from Iflytek Co.,ltd. expands the capital territory with another success.
① Iflytek Co.,ltd. Medical is derived from Iflytek Co.,ltd. Focusing on the field of AI, Liu Qingfeng's Iflytek Co.,ltd. has made arrangements in multiple areas, including Education, Medical, Siasun Robot&Automation, and other fields. ② However, the AI Medical Business involves patient information, and the 'Iflytek Xiaoyi' application developed by Iflytek Medical has issues with collecting personal information beyond the scope, as reported by the Ministry of Industry and Information Technology.
The State Council meeting deployed to deepen the regulatory reform of Pharmaceutical and medical instruments, and Institutions indicated that there are significant structural opportunities in the Pharmaceutical Industry.
According to media reports, the recent State Council executive meeting deployed measures to deepen the regulation reform of pharmaceuticals and medical instruments, promoting the high-quality development of the pharmaceutical industry. Orient stated that looking back at 2024, the high base from the past has been digested, and the intra-hospital rigid demand is being released normally. Meanwhile, the Industry Chain of Innovative Drugs and the export of instruments continue to yield results, and the overall growth logic is clearly visible.
Huawei Shengsi Artificial Intelligence Framework Summit will soon be held to accelerate the prosperity of AI applications
① According to media reports, on December 14, the Shengsi Artificial Intelligence Framework Summit will be held in Beijing. ② CITIC Securities said that the model ecosystem is booming rapidly, and it is expected that in 2025, with the support of upgrading model capabilities and lowering the threshold for industrialization, combined with the implementation of applications such as agents, the commercialization of AI will continue to accelerate.